Hubei Biocause Pharmaceutical Co., Ltd. announced on 24 April 2023 the final profit distribution proposal for 2022 as Cash dividend/10 shares (tax included): CNY 1.10000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.38 CNY | -4.03% | +1.28% | -16.20% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.20% | 1.62B | |
+6.58% | 74.49B | |
+6.64% | 50.15B | |
+0.85% | 47.28B | |
+12.23% | 43.12B | |
+8.25% | 40.31B | |
+20.44% | 38.48B | |
+4.41% | 30.54B | |
-3.72% | 28.79B | |
-14.77% | 26.01B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Hubei Biocause Pharmaceutical Co., Ltd. Announces Final Profit Distribution Proposal for 2022